バイオシミラーリンパ球モジュレータの世界市場（2022年）

当レポートでは、世界のバイオシミラーリンパ球モジュレータ市場について調査分析し、市場の特徴、市場の動向と戦略、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 バイオシミラーリンパ球モジュレータ市場の特徴

第3章 バイオシミラーリンパ球モジュレータ市場の動向と戦略

第4章 バイオシミラーリンパ球モジュレータに対するCOVID-19の影響

第5章 バイオシミラーリンパ球モジュレータの市場規模と成長

• 世界のバイオシミラーリンパ球モジュレータ市場実績、10億米ドル（2016年～2021年）
  • 市場促進要因
  • 市場抑制要因
• 世界のバイオシミラーリンパ球モジュレータ市場予測、10億米ドル（2021年～2026年）（2031年）
  • 市場促進要因
  • 市場抑制要因

第6章 バイオシミラーリンパ球モジュレータ市場のセグメンテーション

• 世界のバイオシミラーリンパ球モジュレータ市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：薬剤別
• Campath-1H
• ナタリズマブバイオシミラー
• エファリズマブ-A1089-抗CD11aバイオシミラー
• 抗CD38ダラツムマブバイオシミラー
• 抗CS1エロツズマブバイオシミラー
• 世界のバイオシミラーリンパ球モジュレータ市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：疾患別
• 関節炎
• 糖尿病
• 多発性骨髄腫
• 腸炎
• 多発性硬化症
• 乾癬
• その他

第7章 バイオシミラーリンパ球モジュレータ市場の地域および国の分析

• 世界のバイオシミラーリンパ球モジュレータ市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：地域別
• 世界のバイオシミラーリンパ球モジュレータ市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：国別

第8章 アジア太平洋地域のバイオシミラーリンパ球モジュレータ市場

第9章 中国のバイオシミラーリンパ球モジュレータ市場

第10章 インドのバイオシミラーリンパ球モジュレータ市場

第11章 日本のバイオシミラーリンパ球モジュレータ市場

第12章 オーストラリアのバイオシミラーリンパ球モジュレータ市場

第13章 インドネシアのバイオシミラーリンパ球モジュレータ市場

第14章 韓国のバイオシミラーリンパ球モジュレータ市場

第15章 西欧のバイオシミラーリンパ球モジュレータ市場

第16章 英国のバイオシミラーリンパ球モジュレータ市場

第17章 ドイツのバイオシミラーリンパ球モジュレータ市場

第18章 フランスのバイオシミラーリンパ球モジュレータ市場

第19章 東欧のバイオシミラーリンパ球モジュレータ市場

第20章 ロシアのバイオシミラーリンパ球モジュレータ市場

第21章 北米のバイオシミラーリンパ球モジュレータ市場

第22章 米国のバイオシミラーリンパ球モジュレータ市場

第23章 南米のバイオシミラーリンパ球モジュレータ市場

第24章 ブラジルのバイオシミラーリンパ球モジュレータ市場

第25章 中東のバイオシミラーリンパ球モジュレータ市場

第26章 アフリカのバイオシミラーリンパ球モジュレータ市場

第27章 バイオシミラーリンパ球モジュレータ市場の競合情勢と企業プロファイル

• バイオシミラーリンパ球モジュレータ市場の競合情勢
• バイオシミラーリンパ球モジュレータ市場の企業プロファイル
  • Pfizer
  • Biogen
  • Genentech
  • Novartis
  • Celltrion

第28章 バイオシミラーリンパ球モジュレータパイプライン分析

第29章 バイオシミラーリンパ球モジュレータ市場における主要な合併と買収

第30章 バイオシミラーリンパ球モジュレータ市場の将来展望と潜在的分析

第31章 付録

“Biosimilar Lymphocyte Modulator Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar lymphocyte modulator market.

This report focuses on biosimilar lymphocyte modulator market which is experiencing strong growth. The report gives a guide to the biosimilar lymphocyte modulator market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilar lymphocyte modulator? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Biosimilar Lymphocyte Modulator market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilar lymphocyte modulator market, and compares it with other markets.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
• The biosimilar lymphocyte modulator market section of the report gives context. It compares the biosimilar lymphocyte modulator market with other segments of the biosimilar lymphocyte modulator market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar lymphocyte modulator indicators comparison.

Scope

Markets Covered:

1) By Drug: Campath-1H; Natalizumab Biosimilar; Efalizumab - A1089-Anti-CD11a Bisoimilar; Anti-CD38 Daratumumab Biosimilar; Anti-CS1 Elotuzumab Bisoimilar

2) By Disease: Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Psoriasis; Others

Companies Mentioned: Pfizer; Biogen; Genentech; Novartis; Celltrion

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilar Lymphocyte Modulator Market Characteristics

3. Biosimilar Lymphocyte Modulator Market Trends And Strategies

4. Impact Of COVID-19 On Biosimilar Lymphocyte Modulator

5. Biosimilar Lymphocyte Modulator Market Size And Growth

• 5.1. Global Biosimilar Lymphocyte Modulator Historic Market, 2016-2021, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Biosimilar Lymphocyte Modulator Forecast Market, 2021-2026F, 2031F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Biosimilar Lymphocyte Modulator Market Segmentation

• 6.1. Global Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
• Campath-1H
• Natalizumab Biosimilar
• Efalizumab - A1089-Anti-CD11a Bisoimilar
• Anti-CD38 daratumumab Biosimilar
• Anti-CS1 elotuzumab Bisoimilar
• 6.2. Global Biosimilar Lymphocyte Modulator Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
• Arthritis
• Diabetes
• Multiple Myeloma
• Enterocolitis
• Multiple Sclerosis
• Psoriasis
• Others

7. Biosimilar Lymphocyte Modulator Market Regional And Country Analysis

• 7.1. Global Biosimilar Lymphocyte Modulator Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
• 7.2. Global Biosimilar Lymphocyte Modulator Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Biosimilar Lymphocyte Modulator Market

• 8.1. Asia-Pacific Biosimilar Lymphocyte Modulator Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Biosimilar Lymphocyte Modulator Market

• 9.1. China Biosimilar Lymphocyte Modulator Market Overview
• 9.2. China Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Biosimilar Lymphocyte Modulator Market

• 10.1. India Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Biosimilar Lymphocyte Modulator Market

• 11.1. Japan Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Biosimilar Lymphocyte Modulator Market

• 12.1. Australia Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Biosimilar Lymphocyte Modulator Market

• 13.1. Indonesia Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Biosimilar Lymphocyte Modulator Market

• 14.1. South Korea Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Biosimilar Lymphocyte Modulator Market

• 15.1. Western Europe Biosimilar Lymphocyte Modulator Market Overview
• 15.2. Western Europe Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Biosimilar Lymphocyte Modulator Market

• 16.1. UK Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Biosimilar Lymphocyte Modulator Market

• 17.1. Germany Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Biosimilar Lymphocyte Modulator Market

• 18.3. France Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Biosimilar Lymphocyte Modulator Market

• 19.1. Eastern Europe Biosimilar Lymphocyte Modulator Market Overview
• 19.2. Eastern Europe Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Biosimilar Lymphocyte Modulator Market

• 20.1. Russia Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Biosimilar Lymphocyte Modulator Market

• 21.1. North America Biosimilar Lymphocyte Modulator Market Overview
• 21.2. North America Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Biosimilar Lymphocyte Modulator Market

• 22.1. USA Biosimilar Lymphocyte Modulator Market Overview
• 22.2. USA Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Biosimilar Lymphocyte Modulator Market

• 23.1. South America Biosimilar Lymphocyte Modulator Market Overview
• 23.2. South America Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Biosimilar Lymphocyte Modulator Market

• 24.1. Brazil Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Biosimilar Lymphocyte Modulator Market

• 25.1. Middle East Biosimilar Lymphocyte Modulator Market Overview
• 25.2. Middle East Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Biosimilar Lymphocyte Modulator Market

• 26.1. Africa Biosimilar Lymphocyte Modulator Market Overview
• 26.2. Africa Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Biosimilar Lymphocyte Modulator Market Competitive Landscape And Company Profiles

• 27.1. Biosimilar Lymphocyte Modulator Market Competitive Landscape
• 27.2. Biosimilar Lymphocyte Modulator Market Company Profiles
  • 27.2.1. Pfizer
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Biogen
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Genentech
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Novartis
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Celltrion
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Biosimilar Lymphocyte Modulator Pipeline Analysis

29. Key Mergers And Acquisitions In The Biosimilar Lymphocyte Modulator Market

30. Biosimilar Lymphocyte Modulator Market Future Outlook and Potential Analysis

31. Appendix

• 31.1. Abbreviations
• 31.2. Currencies
• 31.3. Research Inquiries
• 31.4. The Business Research Company
• 31.5. Copyright And Disclaimer